Skip to main content

Improving Predictability and Transparency in DEA and FDA

Witness
Joseph T. Rannazzisi
Deputy Assistant Administrator, Office Of Diversion Control
Drug Enforcement Administration (DEA)
Committee
House Energy and Commerce Committee, Subcommittee on Health
Session
113th Congress Second Session - 2014
Subject
Improving Predictability and Transparency in DEA and FDA
Date